News

During a live event, Tony Philip, MD, and participants discussed molecular profiling and active surveillance for desmoid ...
Plexiform fibromyxoma is a rare primary mesenchymal tumor of the gastrointestinal tract, first reported by Takahashi in 2007 and officially recognized as a subtype of gastric mesenchymal tumor by the ...
Dr. Breelyn Wilky discusses challenges that patients with GIST face and shares advice with those who feel overwhelmed by the ...
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can help guides treatment decisions.
Breelyn Wilky, MD, discusses what key molecular insights in GIST management community oncologists should prioritize today.
Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and leading causes of ...
Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...
More information: Lisa Schweizer et al, Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression, Cancer Cell (2025).
With limited standard options left, the patient’s case was presented and reviewed by the WIN International Molecular Tumor Board, a global panel of cancer experts.
A molecular pathway used by pancreatic cancer cells to adapt to stress and inflammation could lead to earlier detection and ...
Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors.